pre-miRNA Information
pre-miRNA hsa-mir-16-2   
Genomic Coordinates chr3: 160404745 - 160404825
Description Homo sapiens miR-16-2 stem-loop
Comment This entry represents a second putative hairpin precursor sequence for miR-16, located on chromosome 3 (see also MIR:MI0000070). The sequence was previously named mir-16-3 here and in references .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-16-2-3p
Sequence 53| CCAAUAUUACUGUGCUGCUUUA |74
Evidence Experimental
Experiments Cloned
DRVs in miRNA
Mutant ID Mutant Position Mutant Source
COSN30477465 2 COSMIC
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs746992239 2 dbSNP
rs775368833 4 dbSNP
rs373202341 10 dbSNP
rs768780684 13 dbSNP
rs1341798864 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol ANP32E   
Synonyms LANP-L, LANPL
Description acidic nuclear phosphoprotein 32 family member E
Transcript NM_001136478   
Other Transcripts NM_001136479 , NM_030920   
Expression
Putative miRNA Targets on ANP32E
3'UTR of ANP32E
(miRNA target sites are highlighted)
>ANP32E|NM_001136478|3'UTR
   1 ATCATTCTAAGACCAGATTCTCTAATGTTTCTGGGTGTGCAATAGAGTGATCACATCTTTGTTTCTTCATGTACGATAGC
  81 TATCCCTACAGAAGATAATGTGTAACTTTTTATAGGAAAAGTGTGGTTTTACTATTTTTGCCTTATCATTCCAAATAAGA
 161 ACTAGTCTGTTAATGATCATATTGTATGTAGAGAAAAATTTTCATTGACTCCCATTGTGGAATTCCCTAGCAATTTATTT
 241 AGACTTAATTTTTTAAATTCAAGCTTACTGTATTAGTCATTTTTAGCCCATAATTAAAACATGATCACTTTTACACAGGT
 321 GTAGTATGGTGCATTTCATTCCTTATTTATAAATTAACTGAAATTACAGTTTGCTATAATATAAAATGACAATAGTCTCT
 401 TGAGTGGTAAGTTGGTTATTTTTTTAGAGGTGATCCAGGAATCTTTAGTTTGAAGGCAGTTACCTTTTTTTTTTTTTTTT
 481 TTTGACTAAGAGTGTTTGGTTGCTTTTTTGTCACAAGTAACTTGGAAAATAGAAGCAGAATAGTAAAGGTTCTATTCAGC
 561 AACATAGTTCATGGATTTTGTGGAGGTTCTATTCAGTAATATGGTTCATGGATTTAGTGGTGACTGATAAGATTTTATTT
 641 TTGAAGGAAAAATTGCTTATACTAAGTCCAGAGACATGCAGGTGAGCCCTTTTGTCAGGCTGCAAATCATGACATGCCGA
 721 TGGTTGTTTATTTTGTTTTTAGGTGTGCATTCTTTTTCTTCTTAGCAATTCCTTTATGATCACCTTCCCTTCTTGTTTCA
 801 CTCCCTCCCGCTCTCTCAAAAGGAACTTGGGAAACTTGTGAAACCCAGGAAAACCTTTAGTCTTATACCTCAACTACCTT
 881 TCAGTCCTGTCTGGGTTTTAAATAAGTGAAGTAGAAGAAATTGAGTATTTTCTGACATAAGAATATATTATCAATACAGT
 961 TTTATGCAGTAAGCTCTCCTTACCATAAATGTTTCTTGGTTGACAACATCTAAGACAATATTAGTGGGATGAAGAAAGAA
1041 AAGCAGGGGTGCTTTTGGAAGCAGTGTTAGTGTTCCTCAAAAGTCGGAACAATTGCCTGTTGATATATTAATAAGACATT
1121 AAAGTCAAATTTTAATGTTGGCCTCTCAAATGATTTGGATACCACTCTGCAAAGTATTTCTAACCTTTAATTCCCAGTTT
1201 TAAAACAGATATAATAATAGCATTTAATTGGAATATACTAGGCAGCTGGAAAAGTATTTGAAACTAAATTGACATTAAAA
1281 TTAAGATTTGTTTTCAAGTGGATGTCCATTAAAAGTAGAAAAATATTTGGGATAAGTGAGTGTGTGTTTCCTTACATGGC
1361 TACTAAATAAAATATAATGAGTATACAAGTATATCTCCTCTTTTGCTATGGAGGCTCCATGTTCAAGGCAATGGCTTTTT
1441 AAATCTTGGCTATCTAAAATTTTTTCCCTTTGTTTTGAATATTTGTAAGTTTTTAAGAAGTTAGTGTCAGCAAATTAATT
1521 GAAGTTATGCTTCTATACTGGGACATATTTAAATACTGAGTATAGTACTGCTGCTACTGCTTCTACAATGTAAAATGTAT
1601 GACTTGGTGTTTTAAAGTAAAAATTATGATGTTACTTGTGGAGAAACTAAAAATGTTGTACAACTGACCGAAAGAAAACC
1681 CTTGGGGATAAGTTTAGTGAGGGGATTGGAATCCCCAAAAAGATAACATTTTTCTTCTGCTTTTAAAAACTGAAATTCCC
1761 TGTTCTAGTTCCTAACAATTCTCATTACATACTATGCCAGATTACAAAATACTTATTTTTAAAATGAAATCTATATATTG
1841 ACTTTCTTATCAATCATCTTACTGTGCAATCAAAATTAGAGTACTTTGGTTTGAAAACAACACTTAGAGCCTCCAGATAA
1921 CTTTTAAGACTTATTTAGCTTTGTGGGTGGTATTTTCATGCAAATAAGTAAGGGTGGGTTTTATATTTTGTAGAAGTTTT
2001 CGGTCCTATTTTAATGCTCTTTGTATGGCAGTATGTATATATTGTGTTAAGTTCCTCAAGAATCTCCTTAAAAACTTTGA
2081 AGTTAATACTTTTGTGCAACTGTGTTTTGAATAAAGCCATGACAGTGTTAAAAACAAACAAAAAAATTTGCAGTACTCCT
2161 GATTATTCTTTTATTGTTTTTGACTGTTCCCTGTTTTTTTCTGTGACTGCTGTAACTTAAAGTTTTTGAAACTGAATTGC
2241 TTCAAATAAATTGAAGATTTGTTATAATGATTAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' auuUCGUCGUGUCAU-UAUAACc 5'
             :||||:|: ||| |||||| 
Target 5' tatGGCAGTAT-GTATATATTGt 3'
2024 - 2045 138.00 -12.80
2
miRNA  3' auUUCGUCGUGUCAUUAUAACc 5'
            |||:   |:  ||||:||| 
Target 5' taAAGTCAAATTTTAATGTTGg 3'
1120 - 1141 136.00 -11.00
3
miRNA  3' auUUCGUCGUGUCAUUAUAAcc 5'
            |||:|| | |  ||||||  
Target 5' aaAAGTAG-AAA--AATATTtg 3'
1311 - 1329 135.00 -7.70
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30146944 22 COSMIC
COSN26571178 40 COSMIC
COSN31504813 49 COSMIC
COSN30516710 75 COSMIC
COSN31514827 81 COSMIC
COSN30482250 85 COSMIC
COSN30499063 87 COSMIC
COSN30532688 88 COSMIC
COSN8636160 146 COSMIC
COSN30178037 156 COSMIC
COSN31574409 159 COSMIC
COSN26787866 179 COSMIC
COSN31580981 189 COSMIC
COSN1405688 221 COSMIC
COSN31550598 309 COSMIC
COSN9363068 337 COSMIC
COSN29468357 341 COSMIC
COSN1405687 389 COSMIC
COSN26583836 390 COSMIC
COSN26642094 390 COSMIC
COSN31546144 408 COSMIC
COSN31607436 423 COSMIC
COSN25609922 511 COSMIC
COSN31533591 531 COSMIC
COSN31546753 539 COSMIC
COSN17037504 632 COSMIC
COSN16310597 1053 COSMIC
COSN26829572 1162 COSMIC
COSN22837835 1718 COSMIC
COSN19147305 2009 COSMIC
COSN22160342 2076 COSMIC
COSN30540190 2084 COSMIC
COSN31588742 2101 COSMIC
COSN31540732 2109 COSMIC
COSN31611104 2263 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1455914389 1 dbSNP
rs1320489974 2 dbSNP
rs782818937 8 dbSNP
rs782144349 9 dbSNP
rs1452815761 10 dbSNP
rs1304058672 14 dbSNP
rs781941884 17 dbSNP
rs782314654 22 dbSNP
rs782105871 26 dbSNP
rs781961799 30 dbSNP
rs1227417396 31 dbSNP
rs782400147 34 dbSNP
rs782250445 37 dbSNP
rs782081551 39 dbSNP
rs782703817 43 dbSNP
rs782170800 47 dbSNP
rs1330971305 57 dbSNP
rs1226336657 66 dbSNP
rs903637885 68 dbSNP
rs1267504315 70 dbSNP
rs142580858 74 dbSNP
rs945061569 82 dbSNP
rs896171819 84 dbSNP
rs1235824210 96 dbSNP
rs1482942988 103 dbSNP
rs1056756709 104 dbSNP
rs1177998912 119 dbSNP
rs587637181 132 dbSNP
rs1410365121 137 dbSNP
rs1471847368 156 dbSNP
rs937952842 164 dbSNP
rs1158886155 167 dbSNP
rs1430660817 177 dbSNP
rs1174526340 181 dbSNP
rs1356936072 184 dbSNP
rs1446575705 191 dbSNP
rs1298451483 199 dbSNP
rs926421626 204 dbSNP
rs782333196 209 dbSNP
rs973918912 212 dbSNP
rs1323926230 244 dbSNP
rs1220902496 248 dbSNP
rs1276333198 255 dbSNP
rs1311692826 257 dbSNP
rs1205290557 270 dbSNP
rs782220151 276 dbSNP
rs587767203 301 dbSNP
rs1254326790 320 dbSNP
rs1482178595 328 dbSNP
rs1181671176 335 dbSNP
rs908654613 338 dbSNP
rs1270093157 339 dbSNP
rs1481586408 342 dbSNP
rs1189998276 344 dbSNP
rs147715673 348 dbSNP
rs1425069494 350 dbSNP
rs587616202 352 dbSNP
rs1170501841 355 dbSNP
rs955524756 359 dbSNP
rs1427442590 376 dbSNP
rs782618382 380 dbSNP
rs1306976658 382 dbSNP
rs782471739 386 dbSNP
rs1345914731 387 dbSNP
rs1438271618 389 dbSNP
rs587767591 394 dbSNP
rs372954380 406 dbSNP
rs1276835381 407 dbSNP
rs976030288 409 dbSNP
rs775656829 415 dbSNP
rs1204710166 418 dbSNP
rs1033168980 419 dbSNP
rs1448321110 429 dbSNP
rs1197198646 430 dbSNP
rs1246682042 433 dbSNP
rs1476016594 439 dbSNP
rs1191002963 444 dbSNP
rs587685847 449 dbSNP
rs770178713 461 dbSNP
rs1391509628 464 dbSNP
rs1447056124 465 dbSNP
rs1167584639 479 dbSNP
rs1365795245 482 dbSNP
rs868988665 482 dbSNP
rs1289649119 485 dbSNP
rs1299645776 485 dbSNP
rs1321302662 485 dbSNP
rs1349274544 485 dbSNP
rs1363135604 485 dbSNP
rs1406941407 485 dbSNP
rs1431432855 485 dbSNP
rs1447896474 485 dbSNP
rs1211126905 486 dbSNP
rs145934219 491 dbSNP
rs1246663990 494 dbSNP
rs370955710 496 dbSNP
rs1463204343 500 dbSNP
rs1187385185 511 dbSNP
rs782045947 511 dbSNP
rs1368722861 513 dbSNP
rs118146983 521 dbSNP
rs6679147 541 dbSNP
rs1412808242 542 dbSNP
rs1457522204 546 dbSNP
rs1322538586 550 dbSNP
rs1386357546 555 dbSNP
rs1434520425 558 dbSNP
rs1337447589 564 dbSNP
rs782245698 578 dbSNP
rs1342297801 581 dbSNP
rs1242918106 587 dbSNP
rs1021100617 597 dbSNP
rs1283746144 606 dbSNP
rs1009331921 607 dbSNP
rs1230604102 611 dbSNP
rs1266852875 613 dbSNP
rs896106441 620 dbSNP
rs1207610913 622 dbSNP
rs1256270322 628 dbSNP
rs1443577073 634 dbSNP
rs782764551 656 dbSNP
rs1236524965 667 dbSNP
rs1472834978 679 dbSNP
rs1161070335 681 dbSNP
rs1409732122 687 dbSNP
rs587672294 718 dbSNP
rs1456664212 719 dbSNP
rs782251222 720 dbSNP
rs1404443598 721 dbSNP
rs1394301772 722 dbSNP
rs1333822328 724 dbSNP
rs937925455 729 dbSNP
rs1412107911 736 dbSNP
rs1286824205 741 dbSNP
rs1328852097 743 dbSNP
rs1224697485 765 dbSNP
rs1258226277 767 dbSNP
rs587608801 768 dbSNP
rs905153945 769 dbSNP
rs1198229025 773 dbSNP
rs1277526657 796 dbSNP
rs1483167471 805 dbSNP
rs782669280 806 dbSNP
rs1183837351 810 dbSNP
rs1249392793 811 dbSNP
rs587768263 820 dbSNP
rs1199504715 821 dbSNP
rs1379281320 823 dbSNP
rs1464664667 827 dbSNP
rs1172038050 829 dbSNP
rs941172216 832 dbSNP
rs1431885773 840 dbSNP
rs587686946 850 dbSNP
rs1350271500 860 dbSNP
rs1387696316 863 dbSNP
rs1304139429 869 dbSNP
rs587631758 870 dbSNP
rs147121925 879 dbSNP
rs1273759338 893 dbSNP
rs1342206824 905 dbSNP
rs587669830 907 dbSNP
rs1206863518 928 dbSNP
rs587599062 938 dbSNP
rs1482637437 947 dbSNP
rs1210205758 955 dbSNP
rs186412915 961 dbSNP
rs1431344776 986 dbSNP
rs1198021296 987 dbSNP
rs1390899060 996 dbSNP
rs975472066 1000 dbSNP
rs1451336053 1004 dbSNP
rs587642495 1019 dbSNP
rs1370181055 1026 dbSNP
rs1458774100 1029 dbSNP
rs964275576 1030 dbSNP
rs80110309 1031 dbSNP
rs1388966769 1044 dbSNP
rs1386740256 1048 dbSNP
rs979028516 1049 dbSNP
rs967510179 1051 dbSNP
rs782472308 1052 dbSNP
rs1365316984 1065 dbSNP
rs781839052 1067 dbSNP
rs1229951808 1081 dbSNP
rs1009693531 1086 dbSNP
rs1340979350 1087 dbSNP
rs1267016040 1107 dbSNP
rs111859228 1114 dbSNP
rs1035092222 1119 dbSNP
rs1209170499 1121 dbSNP
rs1248553792 1126 dbSNP
rs1466363636 1141 dbSNP
rs1186721466 1144 dbSNP
rs1389837951 1152 dbSNP
rs1424640617 1167 dbSNP
rs1001855552 1181 dbSNP
rs904885405 1185 dbSNP
rs1367094697 1188 dbSNP
rs1457673513 1192 dbSNP
rs1436694161 1194 dbSNP
rs1317929574 1212 dbSNP
rs782623283 1213 dbSNP
rs1360601370 1216 dbSNP
rs1396279251 1228 dbSNP
rs1038220827 1270 dbSNP
rs1319718500 1275 dbSNP
rs1232453202 1283 dbSNP
rs1331106532 1291 dbSNP
rs1206691290 1312 dbSNP
rs1247529692 1318 dbSNP
rs1483582836 1330 dbSNP
rs782770455 1338 dbSNP
rs1183834202 1339 dbSNP
rs1254326096 1343 dbSNP
rs1423659481 1347 dbSNP
rs1160318734 1348 dbSNP
rs1414895094 1349 dbSNP
rs1456130790 1356 dbSNP
rs1159021657 1358 dbSNP
rs1344095988 1370 dbSNP
rs35516778 1372 dbSNP
rs1448049739 1375 dbSNP
rs1005430509 1391 dbSNP
rs782147216 1394 dbSNP
rs149153823 1398 dbSNP
rs375389811 1398 dbSNP
rs587640758 1403 dbSNP
rs1288775398 1406 dbSNP
rs1352053749 1409 dbSNP
rs782330445 1416 dbSNP
rs1283395740 1431 dbSNP
rs1312903711 1438 dbSNP
rs1212337184 1455 dbSNP
rs182816772 1460 dbSNP
rs1254531554 1476 dbSNP
rs934062257 1484 dbSNP
rs1183109506 1486 dbSNP
rs190688581 1489 dbSNP
rs1471777825 1506 dbSNP
rs1182108228 1512 dbSNP
rs587643148 1525 dbSNP
rs1414584089 1530 dbSNP
rs1177575289 1550 dbSNP
rs587749829 1556 dbSNP
rs1040091798 1558 dbSNP
rs1356883472 1561 dbSNP
rs1433746129 1566 dbSNP
rs1308187534 1575 dbSNP
rs1372188681 1577 dbSNP
rs1407748363 1585 dbSNP
rs1278951483 1589 dbSNP
rs1368179811 1595 dbSNP
rs1221066942 1596 dbSNP
rs942654414 1607 dbSNP
rs1299313731 1610 dbSNP
rs1347195842 1613 dbSNP
rs1206145027 1619 dbSNP
rs587695652 1620 dbSNP
rs868969315 1625 dbSNP
rs114811641 1627 dbSNP
rs1482312616 1659 dbSNP
rs978974754 1664 dbSNP
rs186321795 1665 dbSNP
rs913390021 1670 dbSNP
rs1189942138 1671 dbSNP
rs993047947 1675 dbSNP
rs781955735 1683 dbSNP
rs1453204209 1685 dbSNP
rs782366466 1688 dbSNP
rs1001920898 1694 dbSNP
rs1372013162 1698 dbSNP
rs968989485 1717 dbSNP
rs1427631416 1718 dbSNP
rs36050205 1723 dbSNP
rs782238593 1724 dbSNP
rs1350205925 1735 dbSNP
rs1005422246 1741 dbSNP
rs1438565548 1750 dbSNP
rs887064962 1758 dbSNP
rs1047322897 1762 dbSNP
rs1291648299 1763 dbSNP
rs1370358883 1768 dbSNP
rs1229216596 1769 dbSNP
rs998052018 1773 dbSNP
rs181404714 1777 dbSNP
rs1214153529 1813 dbSNP
rs1039783083 1817 dbSNP
rs1453615464 1824 dbSNP
rs1220016682 1825 dbSNP
rs1252903913 1831 dbSNP
rs942770322 1834 dbSNP
rs188989339 1854 dbSNP
rs904485540 1859 dbSNP
rs1188603161 1863 dbSNP
rs1043120327 1890 dbSNP
rs946275149 1893 dbSNP
rs1474237589 1894 dbSNP
rs1166921491 1902 dbSNP
rs1414264800 1912 dbSNP
rs1406820568 1917 dbSNP
rs587753965 1930 dbSNP
rs1393637018 1954 dbSNP
rs587676259 1960 dbSNP
rs993389353 1962 dbSNP
rs938833302 1966 dbSNP
rs1322669028 1969 dbSNP
rs1363069278 1970 dbSNP
rs1430281903 1977 dbSNP
rs1284940671 1978 dbSNP
rs587598367 1984 dbSNP
rs1358971378 1994 dbSNP
rs1273148866 2002 dbSNP
rs980447918 2003 dbSNP
rs1211076379 2021 dbSNP
rs1249385076 2023 dbSNP
rs1444713785 2034 dbSNP
rs1192043909 2038 dbSNP
rs969148260 2051 dbSNP
rs1473694541 2067 dbSNP
rs1162491491 2071 dbSNP
rs1016546267 2076 dbSNP
rs1416834980 2078 dbSNP
rs587729277 2083 dbSNP
rs1457732118 2093 dbSNP
rs1161198160 2094 dbSNP
rs1382897840 2095 dbSNP
rs1400176681 2096 dbSNP
rs369383815 2122 dbSNP
rs781868576 2124 dbSNP
rs1335179895 2125 dbSNP
rs1342452130 2126 dbSNP
rs1446341514 2127 dbSNP
rs1293091338 2139 dbSNP
rs1025535705 2140 dbSNP
rs587665940 2142 dbSNP
rs1230782803 2145 dbSNP
rs1266721718 2148 dbSNP
rs900972097 2148 dbSNP
rs1204033111 2149 dbSNP
rs1278943681 2150 dbSNP
rs782050887 2159 dbSNP
rs1185294794 2176 dbSNP
rs1256544379 2177 dbSNP
rs12743568 2188 dbSNP
rs1472762107 2191 dbSNP
rs1184327436 2194 dbSNP
rs1361987824 2198 dbSNP
rs1469725038 2200 dbSNP
rs1173208788 2202 dbSNP
rs1404388017 2204 dbSNP
rs1018123484 2217 dbSNP
rs1312434328 2222 dbSNP
rs1371575314 2233 dbSNP
rs1412050954 2239 dbSNP
rs1287080066 2240 dbSNP
rs1335653282 2246 dbSNP
rs1237765294 2247 dbSNP
rs1274958293 2252 dbSNP
rs1346424111 2254 dbSNP
rs781994513 2258 dbSNP
rs904644120 2264 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection ...

- Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell.

Article - Hafner M; Landthaler M; Burger L; Khorshid et al.
- Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Disease 81611.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1 "PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1 ...

- Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods.

Article - Kishore S; Jaskiewicz L; Burger L; Hausser et al.
- Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
Experimental Support 3 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions hESCs (WA-09)
Disease 81611.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine ...

- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development.

Article - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al.
- Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
Experimental Support 4 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions Prostate Tissue
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in SRX1760632. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_C ...

- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.).

Article - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al.
- Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
CLIP-seq Support 1 for dataset GSM545214
Method / RBP PAR-CLIP / AGO3
Cell line / Condition HEK293 / Control
Location of target site ENST00000533654.1 | 3UTR | ACUUUCUUAUCAAUCAUCUUACUGUGCAAUCA
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM545216
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / miR-124 transfection
Location of target site ENST00000533654.1 | 3UTR | ACUUUCUUAUCAAUCAUCUUACUGUGCAAUCAA
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 3 for dataset GSM714644
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / completeT1, repA
Location of target site ENST00000533654.1 | 3UTR | GACUUUCUUAUCAAUCAUCUUACUGUGCAAUCAAAAUUAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 21572407 / GSE28865
CLIP-seq Viewer Link
CLIP-seq Support 4 for dataset GSM714645
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / completeT1, repB
Location of target site ENST00000533654.1 | 3UTR | ACUUUCUUAUCAAUCAUCUUACUGUGCAAUCAAAAUUAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 21572407 / GSE28865
CLIP-seq Viewer Link
CLIP-seq Support 5 for dataset SRR359787
Method / RBP PAR-CLIP / AGO2
Cell line / Condition hESCs (WA-09) / 4-thiouridine, RNase T1
Location of target site ENST00000533654.1 | 3UTR | ACUUUCUUAUCAAUCAUCUUACUGUGCAAUCAAAAUUAGAGUACUUUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 22012620 / SRX103431
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE19783 ER- ER- breast cancer 0.4 1.3e-4 0.417 6.6e-5 79 Click to see details
GSE19536 Breast cancer 0.342 2.5e-4 0.326 4.7e-4 100 Click to see details
GSE34608 Pulmonary tuberculosis and sarcoidosis 0.643 1.1e-3 0.774 3.1e-5 20 Click to see details
GSE38974 Chronic obstructive pulmonary disease 0.517 4.1e-3 0.480 7.6e-3 25 Click to see details
GSE32688 Pancreatic cancer 0.443 5.6e-3 0.368 1.9e-2 32 Click to see details
GSE28544 Breast cancer -0.461 1.2e-2 -0.614 7.1e-4 24 Click to see details
GSE28260 Renal cortex and medulla 0.517 3.5e-2 0.478 4.9e-2 13 Click to see details
GSE17498 Multiple myeloma 0.273 4.4e-2 0.137 2.0e-1 40 Click to see details
GSE21032 Prostate cancer -0.151 8.6e-2 -0.137 1.1e-1 83 Click to see details
GSE42095 Differentiated embryonic stem cells 0.255 1.2e-1 0.350 5.1e-2 23 Click to see details
GSE19350 CNS germ cell tumors 0.328 1.5e-1 0.280 1.9e-1 12 Click to see details
GSE35602 Colorectal cancer stromal tissue 0.201 1.7e-1 0.222 1.4e-1 25 Click to see details
GSE38226 Liver fibrosis -0.088 3.5e-1 0.066 3.9e-1 21 Click to see details
GSE21687 Ependynoma primary tumors -0.048 3.5e-1 0.014 4.6e-1 64 Click to see details
GSE15076 Monocyte-derived dendritic cells -0.103 4.0e-1 -0.100 4.0e-1 9 Click to see details
GSE26953 Aortic valvular endothelial cells -0.022 4.6e-1 -0.137 2.6e-1 24 Click to see details
GSE19783 ER+ ER+ breast cancer -0.02 4.7e-1 -0.057 4.1e-1 20 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
PAAD 0.987 0.01 1.000 0.5 4 Click to see details
ESCA -0.614 0.02 -0.527 0.05 11 Click to see details
PCPG 0.992 0.04 1.000 0.5 3 Click to see details
BRCA 0.187 0.05 0.239 0.01 83 Click to see details
STAD 0.278 0.06 0.190 0.15 31 Click to see details
HNSC 0.237 0.07 0.258 0.05 42 Click to see details
KIRP 0.262 0.07 0.158 0.19 32 Click to see details
LUAD 0.439 0.08 0.364 0.12 12 Click to see details
UCEC -0.311 0.1 -0.258 0.14 19 Click to see details
CHOL -0.439 0.12 -0.583 0.05 9 Click to see details
THCA 0.156 0.12 0.165 0.11 59 Click to see details
LUSC 0.166 0.16 0.127 0.22 38 Click to see details
BLCA 0.223 0.19 0.088 0.36 18 Click to see details
PRAD 0.117 0.21 0.136 0.18 48 Click to see details
KICH 0.142 0.25 -0.015 0.47 25 Click to see details
LIHC 0.075 0.3 0.046 0.38 49 Click to see details
KIRC -0.057 0.32 -0.091 0.23 68 Click to see details
CESC 0.258 0.42 0.500 0.33 3 Click to see details
CESC 0.258 0.42 0.500 0.33 3 Click to see details
CESC 0.258 0.42 0.500 0.33 3 Click to see details
75 hsa-miR-16-2-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT004488 RARB retinoic acid receptor beta 3 1
MIRT038707 NUCKS1 nuclear casein kinase and cyclin dependent kinase substrate 1 1 1
MIRT057208 PPIF peptidylprolyl isomerase F 2 4
MIRT058726 RSBN1 round spermatid basic protein 1 2 8
MIRT074502 NFATC2IP nuclear factor of activated T-cells 2 interacting protein 2 4
MIRT081544 ZNF431 zinc finger protein 431 2 4
MIRT096893 ERBB2IP erbb2 interacting protein 2 2
MIRT105124 MYC MYC proto-oncogene, bHLH transcription factor 2 2
MIRT107898 PTAR1 protein prenyltransferase alpha subunit repeat containing 1 2 4
MIRT109432 KLHL15 kelch like family member 15 2 6
MIRT166742 PAPD7 poly(A) RNA polymerase D7, non-canonical 2 6
MIRT171257 YWHAG tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma 2 2
MIRT192760 B2M beta-2-microglobulin 2 2
MIRT194905 RBBP6 RB binding protein 6, ubiquitin ligase 2 8
MIRT215599 SUB1 SUB1 homolog, transcriptional regulator 2 2
MIRT223632 ATP6V1C1 ATPase H+ transporting V1 subunit C1 2 4
MIRT241605 AMOTL1 angiomotin like 1 2 4
MIRT291174 SH3GLB1 SH3 domain containing GRB2 like, endophilin B1 2 2
MIRT444286 ABCG2 ATP binding cassette subfamily G member 2 (Junior blood group) 2 2
MIRT463285 ZFX zinc finger protein, X-linked 2 4
MIRT471759 NUS1 NUS1 dehydrodolichyl diphosphate synthase subunit 2 8
MIRT479611 CDC25A cell division cycle 25A 2 2
MIRT481497 ARL6IP1 ADP ribosylation factor like GTPase 6 interacting protein 1 2 8
MIRT483117 SH3BP5 SH3 domain binding protein 5 2 2
MIRT502279 GRPEL2 GrpE like 2, mitochondrial 2 8
MIRT507838 CCNT1 cyclin T1 2 2
MIRT508179 MTRNR2L6 MT-RNR2-like 6 2 4
MIRT510576 UBE2D3 ubiquitin conjugating enzyme E2 D3 2 6
MIRT517853 RPS4X ribosomal protein S4, X-linked 2 4
MIRT521690 PRKAA1 protein kinase AMP-activated catalytic subunit alpha 1 2 8
MIRT525070 FRK fyn related Src family tyrosine kinase 2 2
MIRT527082 UBE2E3 ubiquitin conjugating enzyme E2 E3 2 2
MIRT529552 EI24 EI24, autophagy associated transmembrane protein 2 2
MIRT530426 SULT1B1 sulfotransferase family 1B member 1 2 2
MIRT533909 TBC1D15 TBC1 domain family member 15 2 2
MIRT536627 IPO7 importin 7 2 2
MIRT537647 ERGIC2 ERGIC and golgi 2 2 4
MIRT538512 CLCN3 chloride voltage-gated channel 3 2 2
MIRT539219 ANP32E acidic nuclear phosphoprotein 32 family member E 2 6
MIRT539348 AGO2 argonaute 2, RISC catalytic component 2 4
MIRT539954 CCT4 chaperonin containing TCP1 subunit 4 2 2
MIRT541208 HOXA10 homeobox A10 2 2
MIRT543216 TMEM117 transmembrane protein 117 2 2
MIRT543399 DROSHA drosha ribonuclease III 2 2
MIRT546648 RPS6KA5 ribosomal protein S6 kinase A5 2 2
MIRT546852 RAB1A RAB1A, member RAS oncogene family 2 2
MIRT549917 MRPS30 mitochondrial ribosomal protein S30 2 2
MIRT552998 USP46 ubiquitin specific peptidase 46 2 2
MIRT555254 PREPL prolyl endopeptidase-like 2 2
MIRT555956 NRIP1 nuclear receptor interacting protein 1 2 2
MIRT557095 HOXA9 homeobox A9 2 2
MIRT561396 TUBB2A tubulin beta 2A class IIa 2 2
MIRT561654 RNF219 ring finger protein 219 2 2
MIRT563101 PABPC4L poly(A) binding protein cytoplasmic 4 like 2 2
MIRT565979 RNF44 ring finger protein 44 2 2
MIRT572396 CCDC14 coiled-coil domain containing 14 2 2
MIRT574400 TM9SF3 transmembrane 9 superfamily member 3 2 2
MIRT607623 VSNL1 visinin like 1 2 2
MIRT610645 CTGF connective tissue growth factor 2 2
MIRT623379 LPP LIM domain containing preferred translocation partner in lipoma 2 2
MIRT624687 AR androgen receptor 2 2
MIRT632089 ALDH1A2 aldehyde dehydrogenase 1 family member A2 2 2
MIRT644216 CBS cystathionine-beta-synthase 2 2
MIRT647841 BID BH3 interacting domain death agonist 2 2
MIRT651649 WASF2 WAS protein family member 2 2 2
MIRT689064 AGMAT agmatinase 2 2
MIRT698150 TNPO1 transportin 1 2 2
MIRT700516 PTPN14 protein tyrosine phosphatase, non-receptor type 14 2 2
MIRT704081 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 2 2
MIRT705970 ACBD5 acyl-CoA binding domain containing 5 2 2
MIRT715694 COMMD3-BMI1 COMMD3-BMI1 readthrough 2 2
MIRT717184 BMI1 BMI1 proto-oncogene, polycomb ring finger 2 2
MIRT724607 AP3B1 adaptor related protein complex 3 beta 1 subunit 2 2
MIRT724854 IGFBP5 insulin like growth factor binding protein 5 2 2
MIRT725401 LRIG2 leucine rich repeats and immunoglobulin like domains 2 2 2
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-16-2 Diethylstilbestrol approved 448537 Microarray mammosphere-derived epithelial cells (MDEC) 19549897 2009 down-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-miR-16-2-3p Oxaliplatin 6857599 NSC266046 approved resistant High Colorectal Cancer cell line (HCT-116)
hsa-miR-16-2-3p Mitoxantrone 4212 NSC279836 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-16-2-3p Cisplatin 5460033 NSC119875 approved sensitive Low Osteosarcoma cell line (HOS)
hsa-miR-16-2-3p Doxorubicin 31703 NSC123127 approved sensitive Low Osteosarcoma cell line (HOS)
hsa-miR-16-2-3p Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (H460)
hsa-miR-16-2-3p Bortezomib 387447 NSC681239 approved resistant Low Multiple Myeloma tissue
hsa-miR-16-2-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-16-2-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (cytosolic RNA)
hsa-miR-16-2-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CAL-27) (total RNA)
hsa-miR-16-2-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-miR-16-2-3p Doxorubicin 31703 NSC123127 approved sensitive cell line (BAS)
hsa-miR-16-2-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-16-2-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardB)
hsa-miR-16-2-3p Cisplatin 5460033 NSC119875 approved resistant cell line (HCT8)
hsa-miR-16-2-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (IGROV-1)
hsa-miR-16-2-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (MDA-231)
hsa-miR-16-2-3p Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-16-2-3p Gemcitabine 60750 NSC613327 approved resistant cell line (Panc1-GR4)

Error report submission